Results 171 to 180 of about 93,899 (311)

Paracetamol: informació per a la ciutadania [cartell]

open access: yes
Paracetamol; Medicaments; PastillesParacetamol; Medicines; PillsParacetamol; Medicamentos; PastillasInfografia que tracta sobre les pautes i els efectes del ...

core  

Immune effector cell‐associated neurotoxicity syndrome (ICANS) during tebentafusp in metastatic uveal melanoma

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Laura Schreieder   +7 more
wiley   +1 more source

Alveolar Bone Regeneration Using 3D‐Printed, Patient‐Specific, Resorbable PCL Scaffold: Prospective Cohort Study

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Aim To evaluate clinical feasibility of 3D‐printed, patient‐specific, polycaprolactone (PCL) resorbable scaffolds for staged alveolar ridge augmentation. Materials and Methods Ten patients requiring staged bone augmentation underwent digital planning to virtually reconstruct the defect to its original contour.
Jamil Alayan   +2 more
wiley   +1 more source

Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management. [PDF]

open access: yesCurr Pain Headache Rep
Nicolas J   +7 more
europepmc   +1 more source

Caregivers' knowledge about children's paracetamol

open access: yes, 2018
Although safe, paracetamol, commonly used in children, can cause adverse events if not administered correctly. This research aimed to investigate caregivers' knowledge about children's paracetamol.
Judy Mullan (19587883)   +2 more
core  

Management of chronic urticaria: Current status and future prospect

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Chronic urticaria is driven by mast cell activation through autoimmune, inflammatory, and neuroimmune pathways. A structured approach combining diagnosis, patient‐reported outcomes, stepwise therapy, treatment optimization, monitoring and emerging targeted agents may improve disease control and enable more personalized management.
Andaç Salman   +15 more
wiley   +1 more source

Controlled Drug Use and Falls in Older People With Neurogenic Claudication: Secondary Analysis of the BOOST RCT

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Controlled pain medications increase the risk of falls. Despite this, they are commonly prescribed for painful neurogenic claudication. Previously, we reported that the Better Outcomes for Older People with Spinal Trouble (BOOST) program improved walking and reduced overall falls at 12 months.
Helen Richmond‐Davies   +8 more
wiley   +1 more source

Why Paracetamol?

open access: yesJournal of International Medical Research, 1976
B G, Gazzard   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy